![Michelle Mahler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Mahler
Directeur Technique/Scientifique/R&D chez
COMPUGEN LTD.
Fortune : 49 488 $ au 30/06/2026
Profil
Michelle Mahler currently works at Compugen Ltd., as Chief Medical Officer from 2024.
Dr. Mahler also formerly worked at C4 Therapeutics, Inc., as Vice President-Clinical Development from 2020 to 2022 and 1E Therapeutics Ltd., as Chief Medical Officer from 2022 to 2023.
Dr. Mahler received her doctorate degree from the University of the Witwatersrand.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
COMPUGEN LTD. 0,02% | 18/03/2026 | 23 125 ( 0,02% ) | 49 488 $ | 30/06/2026 |
Postes actifs de Michelle Mahler
| Sociétés | Poste | Début |
|---|---|---|
| COMPUGEN LTD. | Directeur Technique/Scientifique/R&D | 01/03/2024 |
Anciens postes connus de Michelle Mahler
| Sociétés | Poste | Fin |
|---|---|---|
1E Therapeutics
 1E Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a drug development company | Directeur Technique/Scientifique/R&D | 01/11/2023 |
| C4 THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/03/2022 |
Formation de Michelle Mahler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Compugen Ltd.
 Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
1E Therapeutics
1E Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a drug development company | Health Technology |
